Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
ClinicalTrials.gov study NCT00902044. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer
ClinicalTrials.gov study NCT03863223. IPD Sharing: NO. Countries: 1. Publications: 1.
DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT04509596. IPD Sharing: NO. Countries: 2. Publications: 1.
A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation
ClinicalTrials.gov study NCT02834936. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
ClinicalTrials.gov study NCT01615068. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
ClinicalTrials.gov study NCT03969121. IPD Sharing: UNDECIDED. Countries: 5. Publications: 1.
68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients
ClinicalTrials.gov study NCT05535621. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06938724. IPD Sharing: NO. Countries: 1. Publications: 2.
DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs
ClinicalTrials.gov study NCT01619111. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
ClinicalTrials.gov study NCT00544804. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer
ClinicalTrials.gov study NCT05747326. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/
ClinicalTrials.gov study NCT03272477. IPD Sharing: NO. Countries: 1. Publications: 40.
Pembrolizumab + Capecitabine/Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive
ClinicalTrials.gov study NCT04249739. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
ClinicalTrials.gov study NCT05256225. IPD Sharing: YES. Countries: 3. Publications: 1.
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
ClinicalTrials.gov study NCT03911973. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
ClinicalTrials.gov study NCT03923179. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer
ClinicalTrials.gov study NCT02433067. IPD Sharing: Not stated. Countries: 1. Publications: 3.
microRNA of Human Epidermal Growth Factor Receptor 2 (HER2)Positive Patient Treated With Herceptin
ClinicalTrials.gov study NCT02656589. IPD Sharing: Not stated. Countries: 1. Publications: 17.
A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer
ClinicalTrials.gov study NCT03809013. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors
ClinicalTrials.gov study NCT04280341. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.